Search Results 41-50 of 17164 for lupus
Diagnosis of discoid/subacute cutaneous lupus erythematosus (DLE/SCLE) for at least 3 months prior to screening visit. · Meets both clinical and ...
Clinical Trials · Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V · More about research at Mayo Clinic.
Lupus: Can it cause hair loss? Fiber supplements: Safe to take every day? Organic baby food: Better for baby? Ovarian cysts and fertility: Is there a ...
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis ... Lupus Nephritis (LN).
This story originally appeared on the In the Loop blog. Regan Birr was diagnosed with lupus when she was 21 years old. In the years since, she tells us her ...
Timothy Niewold has received the Lupus Foundation of America's Mary Betty Stevens Young Investigator Prize for his research on the autoimmune disease lupus. Dr.
The purpose of this study is to evaluate the safety and tolerability of CABA-201 in subjects with active Systemic Lupus Erythematosus. Participation eligibility.
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
These disorders include lupus, which can affect multiple body systems, and Sjogren's syndrome, which causes severe dryness of the mouth and eyes. Transverse ...
Lupus rash. Lupus is an inflammatory disorder that affects a number of body systems. One symptom is the appearance of a bumpy rash on areas of skin exposed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.